Silexion Therapeutics Successfully Initiates Phase 2/3 Clinical Trial of SIL204 in Locally Advanced Pancreatic Cancer at Tel Aviv Sourasky Medical Center
Globe Newswire•29/07/2026•07:00 ET
0
Whiz Insights
Get started
Create a free account to read the full story.